Novel esterase est2 shows cold-adapted activity in Pseudomonas, suggesting potential as a biocatalyst.
Extremozymes from Antarctic microbiota represent a potential source of unique biocatalysts. In this study, a novel esterase gene est2 was identified from the Antarctic bacterium Pseudomonas sp. A6-5. Phylogenetic and sequence analyses classified it as the founding member of a new esterase family XXII. The catalytic triad of the enzyme consisted of Ser 141 , Asp 275 , and His 303 , with the nucleophilic Ser 141 situated within the characteristic GXSXG motif of α/β-hydrolases. Est2 exhibited remarkable cold-adaptation where 20–85% of the maximum activity was observed at temperatures ranging from 0 to 15°C. Substrate specificity profiling revealed preferential hydrolysis of medium-chain p -nitrophenyl esters and triglyceride emulsions. Enzyme activity was sensitive to inhibition by transition metals (1 mM of Mn 2+ , Cu 2+ , Co 2+ , Ni 2+ or Zn 2+ ), but alkali metals were considerably less effective. Representative polar-protic and -aprotic solvents uniformly inhibited Est2 activity. Collectively, these results suggest the structural stability of Est2 is largely governed by hydrophobic interactions and H-bonding, rather than ionic forces. Est2 appears to represent a unique cold-adaptive enzyme that may be suitable for bio-catalyzed environmental remediation.
No takes yet. Share an insight, caveat, or question.
He et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: